Active Ingredient: EZETIMIBE
Proprietary Name: EZETIMIBE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210673
Product Number: 001
Approval Date: Oct 23, 2020
Applicant Holder Full Name: SCIEGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information